JP2022521792A5 - - Google Patents
Info
- Publication number
- JP2022521792A5 JP2022521792A5 JP2021550014A JP2021550014A JP2022521792A5 JP 2022521792 A5 JP2022521792 A5 JP 2022521792A5 JP 2021550014 A JP2021550014 A JP 2021550014A JP 2021550014 A JP2021550014 A JP 2021550014A JP 2022521792 A5 JP2022521792 A5 JP 2022521792A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- dna
- cell
- cancer vaccine
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811459P | 2019-02-27 | 2019-02-27 | |
| US62/811,459 | 2019-02-27 | ||
| US201962825487P | 2019-03-28 | 2019-03-28 | |
| US62/825,487 | 2019-03-28 | ||
| US201962838180P | 2019-04-24 | 2019-04-24 | |
| US62/838,180 | 2019-04-24 | ||
| US201962881832P | 2019-08-01 | 2019-08-01 | |
| US62/881,832 | 2019-08-01 | ||
| PCT/US2020/020224 WO2020176797A1 (en) | 2019-02-27 | 2020-02-27 | Immunotherapeutic combination for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521792A JP2022521792A (ja) | 2022-04-12 |
| JP2022521792A5 true JP2022521792A5 (https=) | 2023-03-06 |
Family
ID=72238533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021550014A Pending JP2022521792A (ja) | 2019-02-27 | 2020-02-27 | 癌を治療するための免疫療法的併用 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3930747A4 (https=) |
| JP (1) | JP2022521792A (https=) |
| CN (1) | CN113631185A (https=) |
| WO (1) | WO2020176797A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230005962A (ko) | 2020-05-01 | 2023-01-10 | 니코데 테라퓨틱스 에이에스에이 | 베타코로나바이러스 예방 및 치료요법 |
| KR20230164118A (ko) | 2021-03-26 | 2023-12-01 | 니코데 테라퓨틱스 에이에스에이 | 암 치료를 위한 치료 조합 |
| WO2022233851A1 (en) | 2021-05-03 | 2022-11-10 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseases |
| EP4337247A1 (en) | 2021-05-10 | 2024-03-20 | Nykode Therapeutics ASA | Tolerance-inducing constructs and compositions and their use for the treatment of immune disorders |
| WO2022238402A1 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Tolerance-inducing constructs and composition and their use for the treatment of immune disorders |
| JP2024518463A (ja) | 2021-05-10 | 2024-05-01 | ナイコード セラピューティクス アルメン アクスイェ セルスカプ | 構築物及び免疫阻害化合物の共発現 |
| WO2022238381A2 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunotherapy constructs for treatment of disease |
| WO2022238363A1 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseases |
| BR112023023260A2 (pt) | 2021-05-10 | 2024-01-30 | Nykode Therapeutics ASA | Vetor, métodos para produzir um vetor e para tratar um sujeito tendo uma doença ou uma doença infecciosa, célula hospedeira, e, composição farmacêutica |
| WO2023079001A1 (en) | 2021-11-03 | 2023-05-11 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of diseases caused by sars-cov-2 |
| WO2024092025A1 (en) | 2022-10-25 | 2024-05-02 | Nykode Therapeutics ASA | Constructs and their use |
| WO2024100196A1 (en) | 2022-11-09 | 2024-05-16 | Nykode Therapeutics ASA | Co-expression of constructs and polypeptides |
| CN116217676B (zh) * | 2023-01-30 | 2025-07-29 | 广州呈源生物免疫技术有限公司 | 人乳头瘤病毒抗原肽及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016025647A1 (en) * | 2014-08-12 | 2016-02-18 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2, a therapeutic antibody, and a cancer vaccine |
| MX2017015149A (es) * | 2015-05-26 | 2018-03-28 | Advaxis Inc | Inmunoterapia personalizada basada en vectores de suministro y usos de esta. |
| IL260030B2 (en) * | 2016-01-08 | 2025-12-01 | Nykode Therapeutics ASA | Therapeutic anticancer neoepitope vaccine |
| JP2019513373A (ja) * | 2016-03-31 | 2019-05-30 | ネオン セラピューティクス， インコーポレイテッド | ネオ抗原およびその使用方法 |
| EP3500966B1 (en) * | 2016-08-25 | 2021-04-21 | Nantomics, LLC | Immunotherapy markers and uses therefor |
| KR20190105568A (ko) * | 2016-11-10 | 2019-09-17 | 넥타르 테라퓨틱스 | 종양의 면역 요법적 치료 방법 |
| WO2018234506A2 (en) * | 2017-06-21 | 2018-12-27 | Transgene Sa | PERSONALIZED VACCINE |
-
2020
- 2020-02-27 WO PCT/US2020/020224 patent/WO2020176797A1/en not_active Ceased
- 2020-02-27 JP JP2021550014A patent/JP2022521792A/ja active Pending
- 2020-02-27 CN CN202080025990.8A patent/CN113631185A/zh active Pending
- 2020-02-27 EP EP20763489.0A patent/EP3930747A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521792A5 (https=) | ||
| Marin-Acevedo et al. | Cancer immunotherapy beyond immune checkpoint inhibitors | |
| Pollack et al. | Emerging targeted and immune-based therapies in sarcoma | |
| Kiesgen et al. | Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies | |
| KR102470294B1 (ko) | 암을 치료하기 위한 항-pd1 항체 및 방사선의 조합 | |
| Dammeijer et al. | Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors | |
| Kandalaft et al. | Immunotherapy for ovarian cancer: what's next? | |
| Coukos et al. | Opportunities in immunotherapy of ovarian cancer | |
| Comoli et al. | Development of adaptive immune effector therapies in solid tumors | |
| Goel et al. | Cancer immunotherapy in clinical practice—the past, present, and future | |
| MX2021011500A (es) | Anticuerpos multiespecificos egfr x cd28. | |
| FI3886875T3 (fi) | Adoptiivista soluterapiaa käyttäviä hoitomenetelmiä | |
| RU2014111999A (ru) | Антитела к C10RF32 и их применения для лечения рака | |
| Houot et al. | Vaccines for lymphomas: idiotype vaccines and beyond | |
| JP2022532490A5 (https=) | ||
| RU2016147206A (ru) | Полипептиды и полинуклеотиды и их применение для лечения иммунологических нарушений и рака | |
| RU2013155455A (ru) | Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6 | |
| RU2011115117A (ru) | Нацеленные средства связывания, направленные на dll4, и их применение | |
| Berinstein | Enhancing cancer vaccines with immunomodulators | |
| CN113543809A (zh) | 用于治疗癌症的免疫疗法 | |
| JP2022512944A5 (https=) | ||
| Ströhlein et al. | The current status of immunotherapy in peritoneal carcinomatosis | |
| IL300629A (en) | Preparations and methods for the treatment of EGFR positive cancer | |
| WO2021055580A3 (en) | An anaplastic lymphoma kinase (alk) cancer vaccine and methods of use | |
| Hegde et al. | Cellular immunotherapy for pediatric solid tumors |